City-based pharmaceutical company Biological E Limited has secured a registration certificate from the Drugs Controller General of India for its BioThrax, which enables the marketing and sale of the vaccine in India to help prevent anthrax infection. Emergent BioSolutions has signed a marketing agreement with Biological E for marketing of BioThrax in the country.
Top Section
Explore Business Standard